EAU Annual Congress Annual Meeting Coverage

Focal Therapy for Prostate Cancer Advances

Focal Therapy for Prostate Cancer Advances

Modalities under investigation include laser ablation, hemiablative seed implantation, and results are promising.

High BMI, Visceral Obesity May Benefit Kidney Cancer Patients

For patients with metastatic disease receiving systemic treatment, a high BMI was found to improve overall survival.

Study Supports RP Use for High-Risk Prostate Cancer

Biochemical recurrence-free and metastasis-free survival can be achieved.

Kidney Stone Emergency Department Visits On the Rise

Kidney Stone Emergency Department Visits On the Rise

The trend is due mostly to an increasing incidence of visits by women.

PSADT Unreliable For Predicting Prostate Cancer Worsening

The finding is based on a study of men with low-risk prostate cancer on active surveillance.

Surgery Lowers RCC-Related Mortality

Partial or radical nephrectomy improves patients' survival odds, data show.

PCNL Use Rises Dramatically in the U.S.

The trend toward increasing use of percutaneous nephrolithotomy is more pronounced among women than men.

Initial MRI May Help Predict Prostate Cancer Progression

MRI-demonstrated tumors at baseline associated with a higher risk of radiologic progression.

Prostatic Arterial Embolization Safe, Effective for BPH

The procedure may be particularly useful in treatment men with prostates larger than 100 cc.

Old Age Alone Should Not Prevent Kidney Transplants

Recipients older than 65 had rates of delayed graft function and graft loss at one year similar to those of younger recipients.

Negative Second Biopsies Do Not Rule Out Prostate Cancer Progression

The absence of cancer on a confirmatory biopsy is associated with a lower risk of volume-related, but not grade-related progression.

More Biopsy Cores Do Not Improve Prostate Cancer Detection

Increasing the number of prostate biopsy cores from 12 to 20 did not increase the likelihood or severity of complication.

Risk Factors for Bladder Tumor Recurrence Identified

In patients with muscle-invasive bladder cancer, those with bladder neck or multiple tumors are more likely to experience recurrent intravesical tumors.

Prostate Cancer Deaths Can Occur Despite Normal Initial PSA

New findings raise questions about PSA screening criteria.

Prostate Cancer Benefit Lasts Up to Nine Years After Last Screening

Stopping PSA testing at age 70 may be premature, at least in men with high-risk disease and long life expectancies, researchers conclude.